GAMMA Investing’s Oruka Therapeutics ORKA Stock Holding History

GAMMA Investing’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31.1K	Buy	374 +250	+202%	+$23.6K	﹤0.01%	2667
2026 Q2	$11.8K	Buy	124 +41	+49%	+$2.73K	﹤0.01%	3123
2026 Q1	$4.07K	Sell	83 -18	-18%	-$626	﹤0.01%	3440
2025 Q4	$3.06K	Buy	+101	New	+$2.81K	﹤0.01%	3469

Other funds holding ORKA

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's ORKA Position: Q3 2026 in Review

GAMMA Investing increased its Oruka Therapeutics (ORKA) stake by 202% in Q3 2026, buying an estimated $23.6K and bringing the position to 374 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2667.

GAMMA Investing first reported a position in ORKA in Q4 2025 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

GAMMA Investing held 374 shares of Oruka Therapeutics worth $31.1K as of Q3 2026.
GAMMA Investing bought 250 Oruka Therapeutics shares in Q3 2026, an estimated $23.6K.
Oruka Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2667 holding.
GAMMA Investing first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 4 quarters since.
4 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.